Stevens Capital Management LP Haemonetics Corp Transaction History

Stevens Capital Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 21, 2020	SELL	$74.34 - $121.82 $253,053 - $414,675	-3,404 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$114.37 - $129.46 $389,315 - $440,681	3,404 New	3,404 $391,000
Q2 2019 Jul 31, 2019	SELL	$81.74 - $120.34 $2.21 Million - $3.25 Million	-27,030 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$83.25 - $102.12 $1.08 Million - $1.32 Million	12,971 Added 92.26%	27,030 $2.37 Million
Q4 2018 Feb 06, 2019	BUY	$90.66 - $116.63 $1.27 Million - $1.64 Million	14,059 New	14,059 $1.41 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $3.11 Million - $3.96 Million	-34,594 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$71.53 - $95.75 $2.47 Million - $3.31 Million	34,594 New	34,594 $3.1 Million
Q1 2018 May 08, 2018	SELL	$60.72 - $74.41 $308,943 - $378,598	-5,088 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$44.96 - $58.99 $242,424 - $318,074	-5,392 Reduced 51.45%	5,088 $296,000
Q3 2017 Nov 01, 2017	BUY	$40.38 - $44.87 $423,182 - $470,237	10,480	10,480 $470,000

347

51.8M

600K

474K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.31B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.